BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 35435948)

  • 1. Hospital-Administered Cancer Therapy Prices for Patients With Private Health Insurance.
    Xiao R; Ross JS; Gross CP; Dusetzina SB; McWilliams JM; Sethi RKV; Rathi VK
    JAMA Intern Med; 2022 Jun; 182(6):603-611. PubMed ID: 35435948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hospital Prices for Pediatric Tympanostomy Tube Placement and Adenotonsillectomy in 2021.
    Miller AL; Xiao R; Rathi VK; Wang AA; Rutter MJ; Hartnick CJ; Sethi RKV
    Laryngoscope; 2023 Apr; 133(4):948-955. PubMed ID: 35678243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variability in expenses related to spine oncology care: comparison of payer-negotiated rates at National Cancer Institute-Designated Cancer Centers.
    Kasthuri VS; Alsoof D; Balmaceno-Criss M; Daher M; McDonald CL; Diebo BG; Kuris EO; Daniels AH
    Spine J; 2024 Feb; 24(2):304-309. PubMed ID: 38440969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hospital Prices for Physician-Administered Drugs for Patients with Private Insurance.
    Robinson JC; Whaley C; Dhruva SS
    N Engl J Med; 2024 Jan; 390(4):338-345. PubMed ID: 38265645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variations in Payer-Negotiated Prices for Head and Neck Reconstructive Surgery.
    Wu SS; Rathi VK; Byrne PJ; Fritz MA; Shaye DA; Lee LN; Sethi RKV; Lindsay RW; Xiao R
    Otolaryngol Head Neck Surg; 2023 Nov; 169(5):1154-1162. PubMed ID: 37337449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hospital-Negotiated Pricing of Cochlear Implants.
    Bartholomew RA; Rathi VK; Suresh K; Sethi RKV; Lee DJ; Xiao R
    Otolaryngol Head Neck Surg; 2023 Sep; 169(3):734-737. PubMed ID: 36939617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Private Payer-Negotiated Prices for Outpatient Otolaryngologic Surgery.
    Wang AA; Xiao R; Sethi RKV; Rathi VK; Scangas GA
    Otolaryngol Head Neck Surg; 2022 Aug; 167(2):262-265. PubMed ID: 34582305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variation in Cost of Echocardiography Within and Across United States Hospitals.
    Wei C; Milligan M; Lam M; Heidenreich PA; Sandhu A
    J Am Soc Echocardiogr; 2023 Jun; 36(6):569-577.e4. PubMed ID: 36638930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Large Variations in the Prices of Urologic Procedures at Academic Medical Centers 1 Year After Implementation of the Price Transparency Final Rule.
    Gul ZG; Sharbaugh DR; Guercio CJ; Pelzman DL; Jones CA; Hacker EC; Anyaeche VI; Bowers L; Shah AM; Stencel MG; Yabes JG; Jacobs BL; Davies BJ
    JAMA Netw Open; 2023 Jan; 6(1):e2249581. PubMed ID: 36602800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Payer-Negotiated Price Variation and Relationship to Surgical Outcomes for the Most Common Cancers at NCI-Designated Cancer Centers.
    Sankaran R; O'Connor J; Nuliyalu U; Diaz A; Nathan H
    Ann Surg Oncol; 2024 Mar; ():. PubMed ID: 38506934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Price-Quality Mismatch: Are Negotiated Prices for Total Joint Arthroplasty Associated With Hospital Quality in a Large California Health System?
    Zhuang T; Shapiro LM; Baker LC; Kamal RN
    Clin Orthop Relat Res; 2023 Jun; 481(6):1061-1068. PubMed ID: 36729581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Private Payer-Negotiated Rates for FDA-Approved Head and Neck Cancer Immunotherapy and Chemotherapy Agents.
    Talwar A; Kim S; Yu S; Samant S; Tozan Y; Givi B
    Otolaryngol Head Neck Surg; 2023 Oct; 169(4):954-961. PubMed ID: 36856039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Provision of Hospital Price Information After Increases in Financial Penalties for Failure to Comply With a US Federal Hospital Price Transparency Rule.
    Kong E; Ji Y
    JAMA Netw Open; 2023 Jun; 6(6):e2320694. PubMed ID: 37378982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of Price Variation in Coronary Artery Bypass Surgery at US Hospitals.
    Wei C; Paranjpe I; Sharma P; Milligan M; Lam M; Heidenreich PA; Kalwani N; Schulman K; Sandhu A
    J Am Heart Assoc; 2024 Feb; 13(4):e031982. PubMed ID: 38362880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in Cancer Care Expenditures and Utilization for Surgery by Hospital Type Among Patients With Private Insurance.
    Takvorian SU; Yasaitis L; Liu M; Lee DJ; Werner RM; Bekelman JE
    JAMA Netw Open; 2021 Aug; 4(8):e2119764. PubMed ID: 34342648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hospital Price Transparency in the United States: An Examination of Chargemaster, Cash, and Negotiated, Price Variation for 14 Common Procedures.
    Linde S; Egede LE
    Med Care; 2022 Oct; 60(10):768-774. PubMed ID: 35948351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Less Than One-third of Hospitals Provide Compliant Price Transparency Information for Total Joint Arthroplasty Procedures.
    Burkhart RJ; Hecht CJ; Acuña AJ; Kamath AF
    Clin Orthop Relat Res; 2022 Dec; 480(12):2316-2326. PubMed ID: 35901439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Beneficiary-Level Risk Factors and Hospital-Level Characteristics With Medicare Part B Drug Spending Differences Between 340B and Non-340B Hospitals.
    Li Y; Xu S
    JAMA Netw Open; 2022 Feb; 5(2):e220045. PubMed ID: 35179584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of Commercial Prices for Common Radiation Therapy Procedures.
    Milligan MG; Orav EJ; Lam MB
    Int J Radiat Oncol Biol Phys; 2023 Jan; 115(1):23-33. PubMed ID: 36309073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Price transparency of prostate cancer care in the United States: An analysis of pricing and disclosure following the centers for medicare and medicaid mandate.
    Brant A; Lewicki P; Rhodes S; Arenas-Gallo C; Strasser MO; Zhu A; Ponsky L; Shoag JE
    Prostate Cancer Prostatic Dis; 2024 Jun; 27(2):252-256. PubMed ID: 36717642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.